dokumendiregister.ee
Sissetulev dokumentAvalik

Infokiri

Terviseamet · 11. juuni 2025
Viit
5-7/25/432-1
Registreeritud
11. juuni 2025
Dokumendi liik
Sissetulev dokument
Adressaat
Roche Diagnostic Solutions
Saabumis/saatmisviis
e-post
Funktsioon
5 Teabe- ja arhiivihaldus
Sari
5-7 Teabenõuded, selgitustaotlused, märgukirjad (sh avaldused, kaebused, taotlused jm pöördumised)
Toimik
5-7/2025
Vastutaja
Liivi Zovo

Failid

Sisu (failidest)

Saatja: "Sobczak, Rachael" <[email protected]> Saaja: [email protected] Teema: SAE Notification - Performance Study 2023-504753-12-00 Kuupäev: 2025-06-10 22:02 Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear Sir/Madam, Please find attached an IVD SAE Report form (IVDR Performance Study Summary Safety Reporting Form MDCG 2024-4 Appendix) for the IVD Performance Evaluation with PSP code RD006691. The SAE is related to a study procedure (sample collection) occurring outside Estonia, and does not directly involve patients in Estonia. Testing with the IVD device occurred in Edinburgh, Scotland. The event is reported as the study procedures and testing are conducted under the same IVD protocol that will be used for Estonian patients. The device manufacturer causality assessment has found that the SAE was not related to the device. Please advise if any additional information is required. Kind regards, Rachael Sobczak Global Studies Leader IQVIA Agent representing Roche Diagnostic Solutions Mobile: 317-965-7205 Email: <mailto:[email protected]> [email protected] Upcoming OOO: N/A
Allikas: Terviseamet dokumendiregister →